Viability assessment and transplantation of extended criteria donor liver grafts using normothermic machine perfusion.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
19 Jun 2024
Historique:
received: 03 02 2024
revised: 26 04 2024
accepted: 15 05 2024
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 20 6 2024
Statut: aheadofprint

Résumé

The scarcity of available liver grafts necessitates the use of organs from extended criteria donors, a practice associated with an increased risk of graft failure. A notable percentage of deceased donor liver allografts are rejected due to subjective criteria. Normothermic machine perfusion holds promise for introducing objective parameters into this decision-making process. The aim of this study was to compare the outcomes of standard criteria and extended criteria donor allografts after liver transplantation, following viability assessment, using normothermic machine perfusion. Liver allografts preserved by normothermic machine perfusion before liver transplantation at the University Hospital of Münster were retrospectively analyzed. Organs were stratified according to the Eurotransplant Donor Risk Index. In total, 101 liver grafts were included in this study and divided into 2 groups: (1) standard criteria donors with a Donor Risk Index <1.8 (DRI-low) and (2) extended criteria donors with a Donor Risk Index ≥1.8 (DRI-high). An increased risk profile of donor livers, as assessed by the Eurotransplant Donor Risk Index, did not correlate with patient or graft survival. High-risk liver grafts were effectively transplanted into recipients with different risk levels after viability assessment by normothermic machine perfusion. However, the recipients' model for end-stage liver disease scores showed a significant association with both overall patient and graft survival. The use of normothermic machine perfusion for viability assessment allows safe transplantation of high-risk donor livers and effectively addresses the disparity between donor liver availability and transplantation demand.

Sections du résumé

BACKGROUND BACKGROUND
The scarcity of available liver grafts necessitates the use of organs from extended criteria donors, a practice associated with an increased risk of graft failure. A notable percentage of deceased donor liver allografts are rejected due to subjective criteria. Normothermic machine perfusion holds promise for introducing objective parameters into this decision-making process. The aim of this study was to compare the outcomes of standard criteria and extended criteria donor allografts after liver transplantation, following viability assessment, using normothermic machine perfusion.
METHODS METHODS
Liver allografts preserved by normothermic machine perfusion before liver transplantation at the University Hospital of Münster were retrospectively analyzed. Organs were stratified according to the Eurotransplant Donor Risk Index. In total, 101 liver grafts were included in this study and divided into 2 groups: (1) standard criteria donors with a Donor Risk Index <1.8 (DRI-low) and (2) extended criteria donors with a Donor Risk Index ≥1.8 (DRI-high).
RESULTS RESULTS
An increased risk profile of donor livers, as assessed by the Eurotransplant Donor Risk Index, did not correlate with patient or graft survival. High-risk liver grafts were effectively transplanted into recipients with different risk levels after viability assessment by normothermic machine perfusion. However, the recipients' model for end-stage liver disease scores showed a significant association with both overall patient and graft survival.
CONCLUSION CONCLUSIONS
The use of normothermic machine perfusion for viability assessment allows safe transplantation of high-risk donor livers and effectively addresses the disparity between donor liver availability and transplantation demand.

Identifiants

pubmed: 38902125
pii: S0039-6060(24)00325-8
doi: 10.1016/j.surg.2024.05.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Thomas Vogel (T)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Carsten Szardenings (C)

Institute of Biostatistics and Clinical Research, University Münster, Germany.

Felix Becker (F)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Stephanie Jordan (S)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Shadi Katou (S)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Haluk Morgul (H)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Isabelle Flammang (I)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Philipp Houben (P)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Felicia Kneifel (F)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany. Electronic address: felicia.kneifel@ukmuenster.de.

Andreas Pascher (A)

Department of General, Visceral, and Transplant Surgery, University Hospital Münster, Germany.

Classifications MeSH